News

Epstein-Barr Virus (EBV) doesn't directly cause cancer, but infection with this common herpes virus brings an increased risk of some cancers, including fast-growing lymphomas. This week researchers report on a new drug that works by targeting EBV-positive tumors.

A research group has announced that DNA sequenced from an ancient bone fragment found in a cave in Russia suggests it came from a hybrid of two now-extinct groups of archaic humans, Neanderthals and Denisovans. The findings shed light on how these two species interacted and implies that Denisovan/Neanderthal mating was far more common than first thought.

Ending a 40-Year Quest.

A UNIGE team has discovered which brain zones are activated in anger, and how the brain suppresses the resulting act of revenge.

In UCLA study, magnetic stimulation of lower spine eliminates need for catheter for up to 4 weeks.

New study in mice reveals master regulator proteins which influence 24 hour metabolic rhythms in muscle cells.

A new genome editing technique is estimated to be 100 to 1,000 times more efficient than current methods, gives users complete spatiotemporal control of the genome editing delivery, in effect allowing them to decide exactly when and where to release genome editing proteins.

DNA contributed by Sub-Saharan African women has been sequenced in an effort to understand the genetic bases for breast cancer in African populations. African and African American women are more likely than women of other ancestries to develop and to die from triple-negative breast cancer, and the new study identifies the genes responsible for inherited breast cancer in Nigerian women.

One challenge in the fight against bacterial disease is that pathogenic bacteria are extraordinarily resilient. Some bacteria accomplish this resilience by using a protein called Dps, which protects bacterial DNA from being damaged. In a new paper, researchers describe some of the unique characteristics of Dps that help bacteria survive stressful conditions. Their research may help lead to more targeted antibiotics and other drug therapies.

Scientists at the John Innes Centre are relying on automatic photobioreactors from algal specialists Algenuity.